Pharma and Biotech
Total Voting Rights | 30-Apr-2024 | 17:00 | RNS |
Final results for the year ended 31 December 2023 | 30-Apr-2024 | 09:12 | RNS |
Holding(s) in Company | 23-Apr-2024 | 11:20 | RNS |
Licensing and Partnership MoU for North America | 02-Apr-2024 | 07:00 | RNS |
Placing to raise £0.62 million | 26-Mar-2024 | 07:00 | RNS |
Interim Results | 28-Sep-2023 | 07:00 | RNS |
Update on Put Option with Conduit | 21-Sep-2023 | 07:00 | RNS |
Completion of Evaluation Programme with Bio-Techne | 19-Sep-2023 | 07:00 | RNS |
Extension of and update on Put Option with Conduit | 08-Sep-2023 | 07:03 | RNS |
Update on Put Option with Conduit | 15-Aug-2023 | 07:00 | RNS |
Expansion of Research Agreement and CIZ1B Update | 10-Aug-2023 | 07:00 | RNS |
Total Voting Rights | 30-Jun-2023 | 17:00 | RNS |
Result of AGM | 28-Jun-2023 | 12:01 | RNS |
Total Voting Rights | 12-Jun-2023 | 14:15 | RNS |
Subscription to raise £350,000 | 12-Jun-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 1.70p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 3.20 |
52 Week Low | 1.60 |
Volume | 132,912 |
Shares Issued | 396.39m |
Market Cap | £6.74m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:50 | 110 @ 1.80p |
11:19 | 13,740 @ 1.72p |
11:05 | 15,000 @ 1.73p |
10:09 | 5 @ 1.60p |
10:06 | 166 @ 1.80p |
Finance Director | Nigel Ronald Lee |
You are here: research